InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（9 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
9
T+90 胜率
50%
T+90 平均收益
+35.5%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Cox John, 首席执行官. Officer active across 3 companies, notably Dyne Therapeutics, Inc.. Aggregated, 16 reports have been recorded. Split: 2 buys · 9 sells. Total volume traded: €1.3m. History available since 4 September 2024. The latest transaction was filed on 8 September 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cox John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
16 条申报中的 16 条
About Cox John
Cox John is Directeur Général and has made 14 filings in total. In the recent filings we hold, the period runs from 2016-02-09 to 2026-06-17, with EUR 804397 of buys and EUR 257143 of sells, and the most frequent transaction type is Cession. He is associated with Dyne Therapeutics, Inc., BIOGEN INC., and Sigilon Therapeutics, Inc.
